We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Eisai has formed a research collaboration to support oncology drug discovery using proteolysis targeting chimeras (PROTAC), which comprise two covalently linked protein-binding molecules.
The University of Dundee Drug Discovery Unit has announced it has entered into a drug development partnership focused on tau pathology with Japanese pharmaceutical giant Takeda.....